FLAGSTAFF, W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new GORE® EXCLUDER® ...

FLAGSTAFF, Ariz., W. L. Gore & Associates, Inc. (Gore) today announced the Health Canada approval of the GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE), making it the most recent off-the-shelf ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today announced that Brian Peterson, MD, from Saint Louis University, enrolled the first patient in the Gore EXCLUDER Iliac Branch ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) today announced that more than 250,000 patients have been treated* with the GORE® EXCLUDER® AAA Endoprosthesis. The GORE ...

W. L. Gore & Associates has announced it has received FDA approval for new endoprosthesis components, according to a news release. The components are a new large diameter 35 mm trunk-ipsilateral leg ...

W. L. Gore & Associates, Inc. (Gore) today announced the 20 th anniversary of the first implant of the GORE ® EXCLUDER ® AAA Endoprosthesis, the most-studied** endovascular aneurysm repair (EVAR) ...

W.L. Gore & Associates has won new technology status from the Centers for Medicare and Medicaid Services and the associated add-on reimbursement for its Excluder iliac branch endoprosthesis (IBE).

Conglomerate W.L. Gore & Associates announced FDA approval of its Excluder Iliac Branch Endoprosthesis for the treatment of common iliac artery aneurysms or aortoiliac aneurysms. The device is used in ...

A vascular surgeon at Salt Lake City-based Intermountain Health has become the first in the U.S. to use the Gore EXCLUDER Thoracoabdominal Branch Endoprosthesis device for the treatment of an aortic ...

due to the inability to preserve internal iliac arteries. This is excellent news for Japanese patients.” The IBE system provides a treatment range of 6.5-13.5 mm for the internal iliac arteries, and a ...

FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates, Inc. (Gore) will share gender-focused real world aortic treatment insights during a lunch symposium at the 46th Annual VEITHsymposium in New ...

W. L. Gore & Associates, Inc. (Gore) today announced that the Food and Drug Administration (FDA) has consented to the initiation of the clinical study for the new GORE® EXCLUDER® Conformable AAA ...